Publication | Closed Access
A safety and efficacy study of recombinant human interleukin-10 (rHuIL-10) treatment in 329 patients with chronic active Crohn's disease (CACD)
33
Citations
0
References
1998
Year
InflammationChronic Inflammatory DiseasesImmunologyGastroenterologyInflammatory MarkerAutoimmunityChronic Active CrohnUlcerative ColitisRecombinant Human Interleukin-10MedicineEfficacy StudyRheumatoid Arthritis
No additional data available for this publication yet. Check back later!